Patent due diligence is often associated with investment or acquisition, but also arises in a variety of other contexts, including product launch, licensing, or even litigation. While each situation differs, manufacturers attempt to assess risk associated with the target technology, including: (1) freedom to operate, (2) strength of the portfolio, and (3) ownership and enforceability. Each of these interrelated aspects of the due diligence process includes its own analysis. Freedom to operate requires an understanding of the technology and evaluates the risk of infringement from third-party patents. Portfolio strength evaluates the validity, patentability, and scope of protection. Ownership evaluates the transferability and clean title to the portfolio.
Inadequate due diligence may result in wasted resources—investment in technology that carries a significant risk of infringement, easy design-around, or non-transferable rights. Additionally, due diligence often carries demanding time constraints, business pressures, and competitive bidding. Join us as we discuss the various aspects of a due diligence investigation and best practices for successfully identifying and assessing risks. As part of our webinar, we will discuss:
Moderator:
Jennifer H. Roscetti
Speakers:
Timothy P. McAnulty
Jeffrey C. Totten
Wednesday, April 5, 2017
10:00 - 11:00 a.m. PDT
1:00 - 2:00 p.m. EDT
Scheduling Conflict? Finnegan records all hosted webinars. To view the recorded program, simply register for the webinar and you will receive an access link shortly after the live program is complete.
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Panel Discussion
May 5, 2026
London
Articles
Choice of Law in Patent Appeals: The Federal Circuit’s Issue-by-Issue Framework
May/June 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.